Immunotherapy in Bladder Cancer with Keyhole-Limpet Hemocyanin: A Randomized Study
- 1 April 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 139 (4) , 723-726
- https://doi.org/10.1016/s0022-5347(17)42610-3
Abstract
A randomized, controlled study was begun in 1982 on the effect of keyhole-limpet hemocyanin and mitomycin C in the prevention of recurrent superficial bladder cancer (stages pTa to pT1, grades 0 to 3) in 44 patients. All tumors were resected and all patients were presumed to be free of tumor at initiation of the prophylactic instillations. Before the bladder instillation program was begun all patients in the keyhole-limpet hemocyanin group Ia were immunized with 1 mg. keyhole-limpet hemocyanin intracutaneously and then monthly bladder instillation of 10 mg. were given. The control group Ib received 20 mg. mitomycin C monthly. Of the 21 patients in the keyhole-limpet hemocyanin group Ia (mean follow-up 20.7 months) 3 (14.2 per cent) had recurrences, compared to 9 of 23 (39.1 per cent) in the mitomycin C group Ib (mean follow-up 18.3 months). The over-all preventive effect was significantly better (p less than 0.05, chi-square) in keyhole-limpet hemocyanin-treated patients than in those given mitomycin C. In 1984 a new drug study (group II) was started with keyhole-limpet hemocyanin alone, adminitered as in group Ia. Of 81 patients in group II (nonrandomized, mean follow-up 22.8 months) 17 (20.9 per cent) had recurrence. Of the patients given keyhole-limpet hemocyanin 20 of 21 (95.2 per cent) in group Ia and 70 of 81 (86.4 per cent) in group II had complete and partial prevention (downgrading), compared to 16 of 23 (69.5 per cent) in group Ib. Our study was established to analyze the effect of a new method of immunotherapy; no adverse local or systemic side effects were noted.This publication has 14 references indexed in Scilit:
- Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1986
- Bladder Cancer ImmunotherapyJournal of Urology, 1982
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- Identification on I-Ak molecules of a functional site recognized by proliferating T-lymphocytesImmunogenetics, 1982
- Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinomaUrological Research, 1981
- Studies on the Intravesical Action of Topically Administered G 3 H-Doxorubicin Hydrochloride in Men: Plasma Uptake and Tumor PenetrationJournal of Urology, 1980
- Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, 1980
- Anti-keyhole limpet hemocyanin antibody in normal unsensitized individualsJournal of Allergy and Clinical Immunology, 1977
- The effect of Keyhole Limpet Hemocyanin (KLH) on the rat bladderCancer Immunology, Immunotherapy, 1977
- Immunologic Reduction of Bladder Cancer Recurrence RateJournal of Urology, 1974